Conversations on Commercialization: Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US
About this episode
The episode discusses how payer consolidation and PBM influence are reshaping dermatology commercialization with insights from Paul Rittman of Almirall US.
In this episode of The Syneos Health Podcast, Conversations on Commercialization, Tyler Cowan, VP, Commercial speaks with Paul Rittman, President and General Manager of Almirall US, about how payer consolidation and PBM influence are reshaping dermatology commercialization. They discuss how pharmaceutical companies must adapt launch strategy, market access planning and clinical differentiation to succeed in today’s competitive specialty landscape. The conversation explores the g...
People in this episode
Host: Tyler Cowan
Guest: Paul Rittman
Topics covered
- dermatology
- commercialization
- payer consolidation
- PBM influence
- market access planning
- launch strategy
Keywords
- dermatology
- commercialization
- payer consolidation
- PBM
- market access
- launch strategy
- clinical differentiation
Mentioned in this episode
Organizations: Almirall US, Syneos Health
More episodes of The Syneos Health Podcast
- Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale
- Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner
- Introducing: Conversations on Commercialization
- Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role
- Functionally Speaking Series: Regulatory Intelligence, Medical Writing and the AI Inflection Point
- Functionally Speaking Series: Reimagining Site Experience: CRAs, AI and the Future of Functional Models
Explore listener stats, chart rankings, contacts and more on the The Syneos Health Podcast podcast page.